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increased contrast to noise ratio, increased blood-tissue
contrast, and decreased interobserver variability as compared
to FGRE. Substantial differences between SSFP and FGRE for
quantification of cardiac mass and volumes have been reported,
but differences between vendor results using both pulse
sequences has not been characterized.
Methods: 50 cardiac MRI cine studies (25 Siemens 1.5 T, 25
General Electric 1.5 T) were acquired using both SSFP and FGRE
pulse sequences in the same study subject. Cardiac MRI analysis
was performed using QMASS software to determine parameters
of cardiac function including left ventricular (LV) mass, end
diastolic volume (EDV), end systolic volume (ESV), ejection
fraction (EF), stroke volume (SV), and cardiac output (CO). MRI
analysis was first performed by a single trained reader.
Interobserver variability was then assessed compared to a
second reader. Results were assessed by regression and Bland-
Altman analyses (Figure 1).
Results: Mean percentage differences between SSFP and FGRE
values for LV mass, EDV, and ESV were -10.5%, +17.7%, and
+18.6% for Siemens scanners and -14.9%, +12.8%, and +15.0%
for General Electric scanners, respectively (p < 0.0001 for all
values). The relationship between SSFP and FGRE values using
General Electric scanners were linear and highly correlated
(p < 0.001) for LV mass, EDV, and ESV (R2 of 0.93, 0.87, and 0.91,
respectively). For Siemens scanners, the relationship between
SSFP and FGRE was highly correlated (p < 0.001) for LV mass (R2
= 0.90) and moderately correlated (p < 0.001) for EDV (R2 =
0.67) and ESV (R2 = 0.61). The slope (intercept) for EF, SV, and
CO were 0.67 (22.4%), 0.73 (29.5 ml), and 0.61 (2.25 l/min) for
Siemens scanners and 0.81 (11.1%), 0.90 (13.7 ml), and 0.95 (0.63
l/min) for General Electric scanners, respectively. Inter-observer
mean differences (± 2 SD) for LV mass, EDV, and ESV using
Siemens scanners were -2.1 g (-21.9–17.7 g), -16.5 ml (-35.4–
2.4 ml), and -12.1 ml (-32.8–8.5 ml) for SSFP measures and
-12.1 g (-48.1–24.0 ml), -18.7 ml (-37.7–0.3 ml), and -9.7 ml
(-21.0–1.5 ml) for FGRE measures, respectively.
Conclusion: Vendor-specific differences exist when comparing
the relationships between SSFP and FGRE cine MRI for
parameters of cardiac function.
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Introduction: Cardiovascular Magnetic Resonance (CMR)
by delayed enhancement (DE) has proven to visualize
myocardial scarring, but no dedicated studies are available in
thalassemia major.
Purpose: Aim of our study was to investigate the
prevalence, extent, clinical and instrumental correlates of
myocardial fibrosis or necrosis by DE CMR in thalassemia
major patients.
Methods: 115 thalassemia major patients (40 men, mean age
27 ± 8 years) were consecutively examined at our CMR
Laboratory using a 1.5 T scanner (GE Excite). Steady-state free
procession cines were acquired during 8-second breath holds in
sequential 8-mm short axis slices from the atrio-ventricular ring
to the apex to assess biventricular function. Biventricular
function was quantitatively assessed using MASS® software
(Medis, Leiden, The Netherlands).
Contrast delayed enhanced images were acquired in the
same view used for cine CMR from 10 to 15 minutes, after
the Gadobutrol (1.0 mol/L) (0.2 mmoli/Kg) intravenous admin-
istration, using a fast gradient-echo inversion recovery
sequence. Inversion times were adjusted to null the normal
myocardium (from 210 ms to 300 ms) with voxel size of
1.6 × 1.25 × 8.0 mm. The extent of DE areas was quantified
using semi-automatic, previously validated software (HIPPO
DELAY®).
Myocardial iron overload was determined by multislice
multiecho T2*. Three parallel short-axis views of the left
ventricle were obtained by T2* gradient-echo multiecho
sequence. Global LV, mid-ventricular and segmental T2*
values were obtained by a dedicated software (HIPPO MIOT®).
Image analysis provided the mapping of segmental data on 16
segments of the left ventricle, according to the standard AHA/
ACC model.
A twelve lead ECG was performed within one month from CMR,
in absence of clinical cardiovascular events and was read blindly
by the consensus of two cardiologists who were unaware of the
results of the CMR exam.
Results: DE areas were present in 28/115 patients (24%).
Extent of DE was 3.9 ± 2.4%. In 26 patients the location
of fibrosis was not specific and patchy distribution was
prevalent. Two patients showed transmural DE following
coronary distribution. The DE group was significantly
older than the non-DE group (31 ± 7.7 years versus 26 ± 7.7
years, P = 0.004). DE correlated with cardiac risk factors
(P = 0.01), history of cardiac complications (P = 0.001), and anti-
HCV antibodies (P = 0.04). We did not find significant
relation with heart T2* values and biventricular function. Figure 1
shows a thalassemia major patient with no myocardial iron
overload (all 16 segments T2* values > 20 ms) (A) and
transmural DE (black arrows) following coronary distribution
in the apical region (B, C).
A significant correlation was found between the presence of
DE and changes in ECG (ECG abnormal in DE group 22/28
patients and in no-DE group 30/87 patients; chi-square 14.9;
P = 0.0001).
Conclusion: In thalassemia patients the significant presence
of myocardial f ibrosis/necrosis seems to be a time
dependent process correlating with cardiovascular risk
factors and cardiac complications. HCV infection could be a
causal agent in the pathogenesis of myocardial scarring. ECG-
changes showed a good accuracy in predicting myocardial
scarring.
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Introduction: Left ventricular non-compaction (LVNC) is a
congenital cardiomyopathy characterised by left ventricular
hypertrabecularisation and thinning of the compacted myocardial
layer. Due to its high spatial resolution and precise delineation of
the non-compacted layer, cardiac magnetic resonance imaging
(cMRI) is a promising method to image and diagnose LVNC
cardiomyopathy.
Methods: In 19 patients who underwent cMRI for suspected
cardiomyopathy LVNC was diagnosed according to diagnostic
criteria such as a ratio of non-compacted to compacted
myocardium (NC/C-ratio) of >2.3 in diastole [1] and exclusion
of other underlying cardiac pathology or cardiovascular risk
factors. We performed cMRI using a clinical 1.5 Tesla scanner
(Philips Achieva). Left ventricular (LV) function, dimensions and
volumes were assessed using steady-state free precession cine
imaging. The NC/C-ratio was assessed in the lateral LV wall in an
apical, midventricular and basal short-axis slice. Additionally,
delayed contrast enhancement (DCE) imaging was performed.
Results: Of the 19 patients, 6 were women (32%), the mean
age was 41.7 ± 16.8 years. Over the whole study group, LV
function was impaired with a mean ejection fraction of 41 ± 17%.
However, LV ejection fraction was normal in 6 patients (32%). LV
volumes were increased with a mean enddiastolic volume of
Figure 1 (abstract P241)
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